nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CACNA1D—epilepsy syndrome	0.32	0.836	CbGaD
Lercanidipine—CYP2D6—epilepsy syndrome	0.0628	0.164	CbGaD
Lercanidipine—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0238	0.0629	CbGbCtD
Lercanidipine—CYP3A7—Carbamazepine—epilepsy syndrome	0.0199	0.0526	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.0199	0.0526	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.0179	0.0472	CbGbCtD
Lercanidipine—CYP3A7—Phenytoin—epilepsy syndrome	0.0179	0.0472	CbGbCtD
Lercanidipine—CYP3A7—Phenobarbital—epilepsy syndrome	0.0159	0.0421	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.0159	0.0421	CbGbCtD
Lercanidipine—CYP3A7—Midazolam—epilepsy syndrome	0.0157	0.0415	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.0157	0.0415	CbGbCtD
Lercanidipine—CYP3A7—Diazepam—epilepsy syndrome	0.0151	0.0399	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.0151	0.0399	CbGbCtD
Lercanidipine—CYP3A5—Carbamazepine—epilepsy syndrome	0.015	0.0395	CbGbCtD
Lercanidipine—CYP3A5—Phenytoin—epilepsy syndrome	0.0134	0.0354	CbGbCtD
Lercanidipine—CYP3A5—Phenobarbital—epilepsy syndrome	0.012	0.0316	CbGbCtD
Lercanidipine—CYP3A5—Midazolam—epilepsy syndrome	0.0118	0.0311	CbGbCtD
Lercanidipine—CYP3A5—Diazepam—epilepsy syndrome	0.0113	0.0299	CbGbCtD
Lercanidipine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00929	0.0245	CbGbCtD
Lercanidipine—CYP3A5—Valproic Acid—epilepsy syndrome	0.00894	0.0236	CbGbCtD
Lercanidipine—CYP3A4—Felbamate—epilepsy syndrome	0.00864	0.0228	CbGbCtD
Lercanidipine—CYP3A4—Trimethadione—epilepsy syndrome	0.00864	0.0228	CbGbCtD
Lercanidipine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00812	0.0214	CbGbCtD
Lercanidipine—CYP2D6—Propofol—epilepsy syndrome	0.00768	0.0203	CbGbCtD
Lercanidipine—CYP3A4—Clonazepam—epilepsy syndrome	0.00735	0.0194	CbGbCtD
Lercanidipine—CYP3A4—Clobazam—epilepsy syndrome	0.00704	0.0186	CbGbCtD
Lercanidipine—CYP3A4—Rufinamide—epilepsy syndrome	0.00599	0.0158	CbGbCtD
Lercanidipine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00584	0.0154	CbGbCtD
Lercanidipine—CYP3A4—Primidone—epilepsy syndrome	0.00545	0.0144	CbGbCtD
Lercanidipine—CYP3A4—Phenytoin—epilepsy syndrome	0.00523	0.0138	CbGbCtD
Lercanidipine—CYP3A4—Propofol—epilepsy syndrome	0.00488	0.0129	CbGbCtD
Lercanidipine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00466	0.0123	CbGbCtD
Lercanidipine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00466	0.0123	CbGbCtD
Lercanidipine—CYP3A4—Midazolam—epilepsy syndrome	0.0046	0.0121	CbGbCtD
Lercanidipine—CYP3A4—Diazepam—epilepsy syndrome	0.00442	0.0117	CbGbCtD
Lercanidipine—CYP3A4—Zonisamide—epilepsy syndrome	0.00432	0.0114	CbGbCtD
Lercanidipine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00349	0.0092	CbGbCtD
Lercanidipine—CYP3A4—Topiramate—epilepsy syndrome	0.00315	0.0083	CbGbCtD
Lercanidipine—CACNA1D—ear—epilepsy syndrome	0.00107	0.251	CbGeAlD
Lercanidipine—Nimodipine—CACNB4—epilepsy syndrome	0.000684	0.145	CrCbGaD
Lercanidipine—Nitrendipine—CACNA2D2—epilepsy syndrome	0.000472	0.0998	CrCbGaD
Lercanidipine—Felodipine—CACNA2D2—epilepsy syndrome	0.000375	0.0795	CrCbGaD
Lercanidipine—Nisoldipine—CACNA1D—epilepsy syndrome	0.000282	0.0596	CrCbGaD
Lercanidipine—Nitrendipine—CACNA1H—epilepsy syndrome	0.000279	0.0591	CrCbGaD
Lercanidipine—CACNA1D—forebrain—epilepsy syndrome	0.000278	0.0654	CbGeAlD
Lercanidipine—Nimodipine—CACNA1D—epilepsy syndrome	0.000272	0.0576	CrCbGaD
Lercanidipine—Nilvadipine—CACNA1D—epilepsy syndrome	0.000264	0.0558	CrCbGaD
Lercanidipine—Nitrendipine—CACNA1D—epilepsy syndrome	0.000264	0.0558	CrCbGaD
Lercanidipine—CACNA1C—forebrain—epilepsy syndrome	0.000257	0.0604	CbGeAlD
Lercanidipine—CACNA1D—telencephalon—epilepsy syndrome	0.000256	0.0602	CbGeAlD
Lercanidipine—CACNA1C—telencephalon—epilepsy syndrome	0.000236	0.0555	CbGeAlD
Lercanidipine—Felodipine—CACNA1H—epilepsy syndrome	0.000222	0.047	CrCbGaD
Lercanidipine—Nifedipine—CACNA1H—epilepsy syndrome	0.000215	0.0455	CrCbGaD
Lercanidipine—Felodipine—CACNA1D—epilepsy syndrome	0.00021	0.0444	CrCbGaD
Lercanidipine—Nifedipine—CACNA1D—epilepsy syndrome	0.000203	0.0429	CrCbGaD
Lercanidipine—Nicardipine—CACNA1D—epilepsy syndrome	0.0002	0.0423	CrCbGaD
Lercanidipine—CYP2D6—hindbrain—epilepsy syndrome	0.000169	0.0397	CbGeAlD
Lercanidipine—CACNA1D—head—epilepsy syndrome	0.000159	0.0375	CbGeAlD
Lercanidipine—CACNA1D—nervous system—epilepsy syndrome	0.000151	0.0355	CbGeAlD
Lercanidipine—CACNA1C—head—epilepsy syndrome	0.000147	0.0346	CbGeAlD
Lercanidipine—CACNA1D—central nervous system—epilepsy syndrome	0.000146	0.0342	CbGeAlD
Lercanidipine—CACNA1D—cerebellum—epilepsy syndrome	0.000142	0.0334	CbGeAlD
Lercanidipine—CACNA1C—nervous system—epilepsy syndrome	0.00014	0.0328	CbGeAlD
Lercanidipine—CACNA1C—central nervous system—epilepsy syndrome	0.000134	0.0316	CbGeAlD
Lercanidipine—CACNA1C—cerebellum—epilepsy syndrome	0.000131	0.0309	CbGeAlD
Lercanidipine—CACNA1D—brain—epilepsy syndrome	0.000116	0.0272	CbGeAlD
Lercanidipine—Nicardipine—CHRM3—epilepsy syndrome	0.000112	0.0238	CrCbGaD
Lercanidipine—CACNA1C—brain—epilepsy syndrome	0.000107	0.0251	CbGeAlD
Lercanidipine—Nicardipine—CHRM1—epilepsy syndrome	0.000105	0.0222	CrCbGaD
Lercanidipine—CYP2D6—brainstem—epilepsy syndrome	9.68e-05	0.0227	CbGeAlD
Lercanidipine—CYP2D6—forebrain—epilepsy syndrome	9.34e-05	0.022	CbGeAlD
Lercanidipine—CYP2D6—telencephalon—epilepsy syndrome	8.59e-05	0.0202	CbGeAlD
Lercanidipine—Nicardipine—CHRM2—epilepsy syndrome	8.57e-05	0.0181	CrCbGaD
Lercanidipine—Nifedipine—ABCC2—epilepsy syndrome	7.73e-05	0.0164	CrCbGaD
Lercanidipine—Nilvadipine—CYP2C19—epilepsy syndrome	6.98e-05	0.0148	CrCbGaD
Lercanidipine—CYP2D6—head—epilepsy syndrome	5.35e-05	0.0126	CbGeAlD
Lercanidipine—Nicardipine—CYP2C19—epilepsy syndrome	5.29e-05	0.0112	CrCbGaD
Lercanidipine—CYP3A4—nervous system—epilepsy syndrome	5.15e-05	0.0121	CbGeAlD
Lercanidipine—CYP2D6—nervous system—epilepsy syndrome	5.07e-05	0.0119	CbGeAlD
Lercanidipine—CYP3A4—central nervous system—epilepsy syndrome	4.96e-05	0.0117	CbGeAlD
Lercanidipine—CYP2D6—central nervous system—epilepsy syndrome	4.88e-05	0.0115	CbGeAlD
Lercanidipine—CYP2D6—cerebellum—epilepsy syndrome	4.77e-05	0.0112	CbGeAlD
Lercanidipine—Nausea—Levetiracetam—epilepsy syndrome	4.58e-05	0.000287	CcSEcCtD
Lercanidipine—Rash—Vigabatrin—epilepsy syndrome	4.57e-05	0.000286	CcSEcCtD
Lercanidipine—Dizziness—Felbamate—epilepsy syndrome	4.57e-05	0.000286	CcSEcCtD
Lercanidipine—Dermatitis—Vigabatrin—epilepsy syndrome	4.57e-05	0.000286	CcSEcCtD
Lercanidipine—Urethral disorder—Topiramate—epilepsy syndrome	4.56e-05	0.000286	CcSEcCtD
Lercanidipine—Pruritus—Oxcarbazepine—epilepsy syndrome	4.55e-05	0.000285	CcSEcCtD
Lercanidipine—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.55e-05	0.000285	CcSEcCtD
Lercanidipine—Vision blurred—Gabapentin—epilepsy syndrome	4.54e-05	0.000285	CcSEcCtD
Lercanidipine—Headache—Vigabatrin—epilepsy syndrome	4.54e-05	0.000285	CcSEcCtD
Lercanidipine—Vomiting—Diazepam—epilepsy syndrome	4.54e-05	0.000284	CcSEcCtD
Lercanidipine—Anorexia—Valproic Acid—epilepsy syndrome	4.52e-05	0.000283	CcSEcCtD
Lercanidipine—Rash—Diazepam—epilepsy syndrome	4.5e-05	0.000282	CcSEcCtD
Lercanidipine—Dermatitis—Diazepam—epilepsy syndrome	4.49e-05	0.000282	CcSEcCtD
Lercanidipine—Arthralgia—Pregabalin—epilepsy syndrome	4.47e-05	0.00028	CcSEcCtD
Lercanidipine—Myalgia—Pregabalin—epilepsy syndrome	4.47e-05	0.00028	CcSEcCtD
Lercanidipine—Chest pain—Pregabalin—epilepsy syndrome	4.47e-05	0.00028	CcSEcCtD
Lercanidipine—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.47e-05	0.00028	CcSEcCtD
Lercanidipine—Dizziness—Zonisamide—epilepsy syndrome	4.47e-05	0.00028	CcSEcCtD
Lercanidipine—Headache—Diazepam—epilepsy syndrome	4.47e-05	0.00028	CcSEcCtD
Lercanidipine—Anxiety—Pregabalin—epilepsy syndrome	4.46e-05	0.000279	CcSEcCtD
Lercanidipine—Diarrhoea—Clonazepam—epilepsy syndrome	4.46e-05	0.000279	CcSEcCtD
Lercanidipine—Anaemia—Gabapentin—epilepsy syndrome	4.45e-05	0.000279	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.44e-05	0.000278	CcSEcCtD
Lercanidipine—Hypotension—Valproic Acid—epilepsy syndrome	4.43e-05	0.000278	CcSEcCtD
Lercanidipine—Asthenia—Carbamazepine—epilepsy syndrome	4.43e-05	0.000278	CcSEcCtD
Lercanidipine—Diarrhoea—Phenytoin—epilepsy syndrome	4.43e-05	0.000278	CcSEcCtD
Lercanidipine—Discomfort—Pregabalin—epilepsy syndrome	4.42e-05	0.000277	CcSEcCtD
Lercanidipine—Nausea—Fosphenytoin—epilepsy syndrome	4.42e-05	0.000277	CcSEcCtD
Lercanidipine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.4e-05	0.000276	CcSEcCtD
Lercanidipine—Erythema multiforme—Topiramate—epilepsy syndrome	4.4e-05	0.000276	CcSEcCtD
Lercanidipine—Angioedema—Gabapentin—epilepsy syndrome	4.4e-05	0.000276	CcSEcCtD
Lercanidipine—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.4e-05	0.000276	CcSEcCtD
Lercanidipine—Vomiting—Felbamate—epilepsy syndrome	4.39e-05	0.000275	CcSEcCtD
Lercanidipine—Dry mouth—Pregabalin—epilepsy syndrome	4.38e-05	0.000274	CcSEcCtD
Lercanidipine—Pruritus—Carbamazepine—epilepsy syndrome	4.37e-05	0.000274	CcSEcCtD
Lercanidipine—Rash—Felbamate—epilepsy syndrome	4.35e-05	0.000273	CcSEcCtD
Lercanidipine—Eye disorder—Topiramate—epilepsy syndrome	4.35e-05	0.000273	CcSEcCtD
Lercanidipine—Dermatitis—Felbamate—epilepsy syndrome	4.35e-05	0.000273	CcSEcCtD
Lercanidipine—Malaise—Gabapentin—epilepsy syndrome	4.35e-05	0.000272	CcSEcCtD
Lercanidipine—Tinnitus—Topiramate—epilepsy syndrome	4.34e-05	0.000272	CcSEcCtD
Lercanidipine—Vertigo—Gabapentin—epilepsy syndrome	4.33e-05	0.000271	CcSEcCtD
Lercanidipine—Headache—Felbamate—epilepsy syndrome	4.33e-05	0.000271	CcSEcCtD
Lercanidipine—Confusional state—Pregabalin—epilepsy syndrome	4.32e-05	0.000271	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.32e-05	0.000271	CcSEcCtD
Lercanidipine—Flushing—Topiramate—epilepsy syndrome	4.32e-05	0.000271	CcSEcCtD
Lercanidipine—Cardiac disorder—Topiramate—epilepsy syndrome	4.32e-05	0.000271	CcSEcCtD
Lercanidipine—Syncope—Gabapentin—epilepsy syndrome	4.32e-05	0.000271	CcSEcCtD
Lercanidipine—Dizziness—Clonazepam—epilepsy syndrome	4.31e-05	0.00027	CcSEcCtD
Lercanidipine—Nausea—Vigabatrin—epilepsy syndrome	4.3e-05	0.00027	CcSEcCtD
Lercanidipine—Vomiting—Zonisamide—epilepsy syndrome	4.3e-05	0.000269	CcSEcCtD
Lercanidipine—Insomnia—Valproic Acid—epilepsy syndrome	4.29e-05	0.000269	CcSEcCtD
Lercanidipine—Asthenia—Lamotrigine—epilepsy syndrome	4.28e-05	0.000268	CcSEcCtD
Lercanidipine—Dizziness—Phenytoin—epilepsy syndrome	4.28e-05	0.000268	CcSEcCtD
Lercanidipine—Rash—Zonisamide—epilepsy syndrome	4.26e-05	0.000267	CcSEcCtD
Lercanidipine—Paraesthesia—Valproic Acid—epilepsy syndrome	4.26e-05	0.000267	CcSEcCtD
Lercanidipine—Palpitations—Gabapentin—epilepsy syndrome	4.26e-05	0.000267	CcSEcCtD
Lercanidipine—Dermatitis—Zonisamide—epilepsy syndrome	4.26e-05	0.000267	CcSEcCtD
Lercanidipine—Dizziness—Oxcarbazepine—epilepsy syndrome	4.26e-05	0.000267	CcSEcCtD
Lercanidipine—Nausea—Diazepam—epilepsy syndrome	4.24e-05	0.000266	CcSEcCtD
Lercanidipine—Loss of consciousness—Gabapentin—epilepsy syndrome	4.23e-05	0.000265	CcSEcCtD
Lercanidipine—Headache—Zonisamide—epilepsy syndrome	4.23e-05	0.000265	CcSEcCtD
Lercanidipine—Dyspnoea—Valproic Acid—epilepsy syndrome	4.23e-05	0.000265	CcSEcCtD
Lercanidipine—Diarrhoea—Carbamazepine—epilepsy syndrome	4.23e-05	0.000265	CcSEcCtD
Lercanidipine—Angiopathy—Topiramate—epilepsy syndrome	4.22e-05	0.000265	CcSEcCtD
Lercanidipine—Pruritus—Lamotrigine—epilepsy syndrome	4.22e-05	0.000265	CcSEcCtD
Lercanidipine—Shock—Pregabalin—epilepsy syndrome	4.22e-05	0.000264	CcSEcCtD
Lercanidipine—Somnolence—Valproic Acid—epilepsy syndrome	4.22e-05	0.000264	CcSEcCtD
Lercanidipine—Immune system disorder—Topiramate—epilepsy syndrome	4.21e-05	0.000264	CcSEcCtD
Lercanidipine—Nervous system disorder—Pregabalin—epilepsy syndrome	4.21e-05	0.000264	CcSEcCtD
Lercanidipine—Cough—Gabapentin—epilepsy syndrome	4.2e-05	0.000264	CcSEcCtD
Lercanidipine—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.2e-05	0.000263	CcSEcCtD
Lercanidipine—Mediastinal disorder—Topiramate—epilepsy syndrome	4.2e-05	0.000263	CcSEcCtD
Lercanidipine—Tachycardia—Pregabalin—epilepsy syndrome	4.19e-05	0.000262	CcSEcCtD
Lercanidipine—Dyspepsia—Valproic Acid—epilepsy syndrome	4.18e-05	0.000262	CcSEcCtD
Lercanidipine—Skin disorder—Pregabalin—epilepsy syndrome	4.17e-05	0.000261	CcSEcCtD
Lercanidipine—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.15e-05	0.00026	CcSEcCtD
Lercanidipine—Vomiting—Clonazepam—epilepsy syndrome	4.14e-05	0.00026	CcSEcCtD
Lercanidipine—Decreased appetite—Valproic Acid—epilepsy syndrome	4.12e-05	0.000258	CcSEcCtD
Lercanidipine—Felodipine—CYP2D6—epilepsy syndrome	4.12e-05	0.00871	CrCbGaD
Lercanidipine—Alopecia—Topiramate—epilepsy syndrome	4.12e-05	0.000258	CcSEcCtD
Lercanidipine—Vomiting—Phenytoin—epilepsy syndrome	4.11e-05	0.000258	CcSEcCtD
Lercanidipine—Rash—Clonazepam—epilepsy syndrome	4.11e-05	0.000257	CcSEcCtD
Lercanidipine—Dermatitis—Clonazepam—epilepsy syndrome	4.1e-05	0.000257	CcSEcCtD
Lercanidipine—Myalgia—Gabapentin—epilepsy syndrome	4.1e-05	0.000257	CcSEcCtD
Lercanidipine—Chest pain—Gabapentin—epilepsy syndrome	4.1e-05	0.000257	CcSEcCtD
Lercanidipine—Arthralgia—Gabapentin—epilepsy syndrome	4.1e-05	0.000257	CcSEcCtD
Lercanidipine—Nausea—Felbamate—epilepsy syndrome	4.1e-05	0.000257	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.1e-05	0.000257	CcSEcCtD
Lercanidipine—Vomiting—Oxcarbazepine—epilepsy syndrome	4.09e-05	0.000257	CcSEcCtD
Lercanidipine—Fatigue—Valproic Acid—epilepsy syndrome	4.09e-05	0.000256	CcSEcCtD
Lercanidipine—Anxiety—Gabapentin—epilepsy syndrome	4.09e-05	0.000256	CcSEcCtD
Lercanidipine—Anorexia—Pregabalin—epilepsy syndrome	4.09e-05	0.000256	CcSEcCtD
Lercanidipine—Dizziness—Carbamazepine—epilepsy syndrome	4.08e-05	0.000256	CcSEcCtD
Lercanidipine—Diarrhoea—Lamotrigine—epilepsy syndrome	4.08e-05	0.000256	CcSEcCtD
Lercanidipine—Headache—Clonazepam—epilepsy syndrome	4.08e-05	0.000256	CcSEcCtD
Lercanidipine—Rash—Phenytoin—epilepsy syndrome	4.08e-05	0.000256	CcSEcCtD
Lercanidipine—Mental disorder—Topiramate—epilepsy syndrome	4.08e-05	0.000256	CcSEcCtD
Lercanidipine—Dermatitis—Phenytoin—epilepsy syndrome	4.08e-05	0.000256	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.07e-05	0.000255	CcSEcCtD
Lercanidipine—Rash—Oxcarbazepine—epilepsy syndrome	4.06e-05	0.000254	CcSEcCtD
Lercanidipine—Constipation—Valproic Acid—epilepsy syndrome	4.06e-05	0.000254	CcSEcCtD
Lercanidipine—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.05e-05	0.000254	CcSEcCtD
Lercanidipine—Headache—Phenytoin—epilepsy syndrome	4.05e-05	0.000254	CcSEcCtD
Lercanidipine—Erythema—Topiramate—epilepsy syndrome	4.05e-05	0.000254	CcSEcCtD
Lercanidipine—Malnutrition—Topiramate—epilepsy syndrome	4.05e-05	0.000254	CcSEcCtD
Lercanidipine—Discomfort—Gabapentin—epilepsy syndrome	4.05e-05	0.000254	CcSEcCtD
Lercanidipine—Headache—Oxcarbazepine—epilepsy syndrome	4.03e-05	0.000253	CcSEcCtD
Lercanidipine—Nausea—Zonisamide—epilepsy syndrome	4.02e-05	0.000252	CcSEcCtD
Lercanidipine—Dry mouth—Gabapentin—epilepsy syndrome	4.01e-05	0.000251	CcSEcCtD
Lercanidipine—Hypotension—Pregabalin—epilepsy syndrome	4.01e-05	0.000251	CcSEcCtD
Lercanidipine—Nifedipine—CYP2D6—epilepsy syndrome	3.98e-05	0.00843	CrCbGaD
Lercanidipine—Tension—Topiramate—epilepsy syndrome	3.98e-05	0.000249	CcSEcCtD
Lercanidipine—Dysgeusia—Topiramate—epilepsy syndrome	3.97e-05	0.000249	CcSEcCtD
Lercanidipine—Confusional state—Gabapentin—epilepsy syndrome	3.97e-05	0.000249	CcSEcCtD
Lercanidipine—Nisoldipine—ABCB1—epilepsy syndrome	3.95e-05	0.00836	CrCbGaD
Lercanidipine—Dizziness—Lamotrigine—epilepsy syndrome	3.95e-05	0.000247	CcSEcCtD
Lercanidipine—Nervousness—Topiramate—epilepsy syndrome	3.94e-05	0.000247	CcSEcCtD
Lercanidipine—Vomiting—Carbamazepine—epilepsy syndrome	3.93e-05	0.000246	CcSEcCtD
Lercanidipine—Nicardipine—CYP2D6—epilepsy syndrome	3.92e-05	0.0083	CrCbGaD
Lercanidipine—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.91e-05	0.000245	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.91e-05	0.000245	CcSEcCtD
Lercanidipine—Muscle spasms—Topiramate—epilepsy syndrome	3.9e-05	0.000244	CcSEcCtD
Lercanidipine—Rash—Carbamazepine—epilepsy syndrome	3.89e-05	0.000244	CcSEcCtD
Lercanidipine—Dermatitis—Carbamazepine—epilepsy syndrome	3.89e-05	0.000244	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.88e-05	0.000243	CcSEcCtD
Lercanidipine—Insomnia—Pregabalin—epilepsy syndrome	3.88e-05	0.000243	CcSEcCtD
Lercanidipine—CYP2D6—brain—epilepsy syndrome	3.88e-05	0.00911	CbGeAlD
Lercanidipine—Nausea—Clonazepam—epilepsy syndrome	3.87e-05	0.000243	CcSEcCtD
Lercanidipine—Headache—Carbamazepine—epilepsy syndrome	3.87e-05	0.000243	CcSEcCtD
Lercanidipine—Shock—Gabapentin—epilepsy syndrome	3.87e-05	0.000243	CcSEcCtD
Lercanidipine—Nervous system disorder—Gabapentin—epilepsy syndrome	3.86e-05	0.000242	CcSEcCtD
Lercanidipine—Paraesthesia—Pregabalin—epilepsy syndrome	3.85e-05	0.000241	CcSEcCtD
Lercanidipine—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.85e-05	0.000241	CcSEcCtD
Lercanidipine—Nausea—Phenytoin—epilepsy syndrome	3.84e-05	0.000241	CcSEcCtD
Lercanidipine—Tachycardia—Gabapentin—epilepsy syndrome	3.84e-05	0.000241	CcSEcCtD
Lercanidipine—Dyspnoea—Pregabalin—epilepsy syndrome	3.82e-05	0.00024	CcSEcCtD
Lercanidipine—Nausea—Oxcarbazepine—epilepsy syndrome	3.82e-05	0.00024	CcSEcCtD
Lercanidipine—Vision blurred—Topiramate—epilepsy syndrome	3.82e-05	0.000239	CcSEcCtD
Lercanidipine—Skin disorder—Gabapentin—epilepsy syndrome	3.82e-05	0.000239	CcSEcCtD
Lercanidipine—Somnolence—Pregabalin—epilepsy syndrome	3.81e-05	0.000239	CcSEcCtD
Lercanidipine—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.8e-05	0.000238	CcSEcCtD
Lercanidipine—Vomiting—Lamotrigine—epilepsy syndrome	3.8e-05	0.000238	CcSEcCtD
Lercanidipine—Urticaria—Valproic Acid—epilepsy syndrome	3.77e-05	0.000236	CcSEcCtD
Lercanidipine—Rash—Lamotrigine—epilepsy syndrome	3.76e-05	0.000236	CcSEcCtD
Lercanidipine—Ill-defined disorder—Topiramate—epilepsy syndrome	3.76e-05	0.000236	CcSEcCtD
Lercanidipine—Dermatitis—Lamotrigine—epilepsy syndrome	3.76e-05	0.000236	CcSEcCtD
Lercanidipine—Body temperature increased—Valproic Acid—epilepsy syndrome	3.75e-05	0.000235	CcSEcCtD
Lercanidipine—Abdominal pain—Valproic Acid—epilepsy syndrome	3.75e-05	0.000235	CcSEcCtD
Lercanidipine—Anorexia—Gabapentin—epilepsy syndrome	3.75e-05	0.000235	CcSEcCtD
Lercanidipine—Anaemia—Topiramate—epilepsy syndrome	3.75e-05	0.000235	CcSEcCtD
Lercanidipine—Headache—Lamotrigine—epilepsy syndrome	3.74e-05	0.000234	CcSEcCtD
Lercanidipine—Decreased appetite—Pregabalin—epilepsy syndrome	3.73e-05	0.000234	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.7e-05	0.000232	CcSEcCtD
Lercanidipine—Fatigue—Pregabalin—epilepsy syndrome	3.7e-05	0.000232	CcSEcCtD
Lercanidipine—Nitrendipine—ABCB1—epilepsy syndrome	3.69e-05	0.00782	CrCbGaD
Lercanidipine—Hypotension—Gabapentin—epilepsy syndrome	3.67e-05	0.00023	CcSEcCtD
Lercanidipine—Nausea—Carbamazepine—epilepsy syndrome	3.67e-05	0.00023	CcSEcCtD
Lercanidipine—Constipation—Pregabalin—epilepsy syndrome	3.67e-05	0.00023	CcSEcCtD
Lercanidipine—Malaise—Topiramate—epilepsy syndrome	3.66e-05	0.000229	CcSEcCtD
Lercanidipine—Vertigo—Topiramate—epilepsy syndrome	3.64e-05	0.000228	CcSEcCtD
Lercanidipine—Syncope—Topiramate—epilepsy syndrome	3.64e-05	0.000228	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.58e-05	0.000225	CcSEcCtD
Lercanidipine—Palpitations—Topiramate—epilepsy syndrome	3.58e-05	0.000225	CcSEcCtD
Lercanidipine—Loss of consciousness—Topiramate—epilepsy syndrome	3.56e-05	0.000223	CcSEcCtD
Lercanidipine—Insomnia—Gabapentin—epilepsy syndrome	3.56e-05	0.000223	CcSEcCtD
Lercanidipine—Nausea—Lamotrigine—epilepsy syndrome	3.55e-05	0.000222	CcSEcCtD
Lercanidipine—Cough—Topiramate—epilepsy syndrome	3.54e-05	0.000222	CcSEcCtD
Lercanidipine—Feeling abnormal—Pregabalin—epilepsy syndrome	3.53e-05	0.000222	CcSEcCtD
Lercanidipine—Paraesthesia—Gabapentin—epilepsy syndrome	3.53e-05	0.000221	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.51e-05	0.00022	CcSEcCtD
Lercanidipine—Dyspnoea—Gabapentin—epilepsy syndrome	3.51e-05	0.00022	CcSEcCtD
Lercanidipine—Somnolence—Gabapentin—epilepsy syndrome	3.5e-05	0.000219	CcSEcCtD
Lercanidipine—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.49e-05	0.000219	CcSEcCtD
Lercanidipine—Dyspepsia—Gabapentin—epilepsy syndrome	3.46e-05	0.000217	CcSEcCtD
Lercanidipine—Myalgia—Topiramate—epilepsy syndrome	3.45e-05	0.000216	CcSEcCtD
Lercanidipine—Chest pain—Topiramate—epilepsy syndrome	3.45e-05	0.000216	CcSEcCtD
Lercanidipine—Arthralgia—Topiramate—epilepsy syndrome	3.45e-05	0.000216	CcSEcCtD
Lercanidipine—Anxiety—Topiramate—epilepsy syndrome	3.44e-05	0.000216	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.43e-05	0.000215	CcSEcCtD
Lercanidipine—Decreased appetite—Gabapentin—epilepsy syndrome	3.42e-05	0.000214	CcSEcCtD
Lercanidipine—Discomfort—Topiramate—epilepsy syndrome	3.41e-05	0.000214	CcSEcCtD
Lercanidipine—Urticaria—Pregabalin—epilepsy syndrome	3.41e-05	0.000214	CcSEcCtD
Lercanidipine—Asthenia—Valproic Acid—epilepsy syndrome	3.4e-05	0.000213	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.4e-05	0.000213	CcSEcCtD
Lercanidipine—Fatigue—Gabapentin—epilepsy syndrome	3.39e-05	0.000213	CcSEcCtD
Lercanidipine—Body temperature increased—Pregabalin—epilepsy syndrome	3.39e-05	0.000213	CcSEcCtD
Lercanidipine—Abdominal pain—Pregabalin—epilepsy syndrome	3.39e-05	0.000213	CcSEcCtD
Lercanidipine—Dry mouth—Topiramate—epilepsy syndrome	3.38e-05	0.000212	CcSEcCtD
Lercanidipine—Constipation—Gabapentin—epilepsy syndrome	3.36e-05	0.000211	CcSEcCtD
Lercanidipine—Pruritus—Valproic Acid—epilepsy syndrome	3.36e-05	0.00021	CcSEcCtD
Lercanidipine—Confusional state—Topiramate—epilepsy syndrome	3.34e-05	0.000209	CcSEcCtD
Lercanidipine—Shock—Topiramate—epilepsy syndrome	3.25e-05	0.000204	CcSEcCtD
Lercanidipine—Diarrhoea—Valproic Acid—epilepsy syndrome	3.25e-05	0.000203	CcSEcCtD
Lercanidipine—Nervous system disorder—Topiramate—epilepsy syndrome	3.24e-05	0.000203	CcSEcCtD
Lercanidipine—Feeling abnormal—Gabapentin—epilepsy syndrome	3.24e-05	0.000203	CcSEcCtD
Lercanidipine—Thrombocytopenia—Topiramate—epilepsy syndrome	3.24e-05	0.000203	CcSEcCtD
Lercanidipine—Tachycardia—Topiramate—epilepsy syndrome	3.23e-05	0.000202	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.22e-05	0.000202	CcSEcCtD
Lercanidipine—Skin disorder—Topiramate—epilepsy syndrome	3.21e-05	0.000201	CcSEcCtD
Lercanidipine—Hyperhidrosis—Topiramate—epilepsy syndrome	3.2e-05	0.0002	CcSEcCtD
Lercanidipine—Hypersensitivity—Pregabalin—epilepsy syndrome	3.16e-05	0.000198	CcSEcCtD
Lercanidipine—Anorexia—Topiramate—epilepsy syndrome	3.15e-05	0.000198	CcSEcCtD
Lercanidipine—Dizziness—Valproic Acid—epilepsy syndrome	3.14e-05	0.000197	CcSEcCtD
Lercanidipine—Urticaria—Gabapentin—epilepsy syndrome	3.12e-05	0.000196	CcSEcCtD
Lercanidipine—Body temperature increased—Gabapentin—epilepsy syndrome	3.11e-05	0.000195	CcSEcCtD
Lercanidipine—Abdominal pain—Gabapentin—epilepsy syndrome	3.11e-05	0.000195	CcSEcCtD
Lercanidipine—Hypotension—Topiramate—epilepsy syndrome	3.09e-05	0.000194	CcSEcCtD
Lercanidipine—Asthenia—Pregabalin—epilepsy syndrome	3.08e-05	0.000193	CcSEcCtD
Lercanidipine—Pruritus—Pregabalin—epilepsy syndrome	3.03e-05	0.00019	CcSEcCtD
Lercanidipine—Vomiting—Valproic Acid—epilepsy syndrome	3.02e-05	0.000189	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.01e-05	0.000189	CcSEcCtD
Lercanidipine—Insomnia—Topiramate—epilepsy syndrome	2.99e-05	0.000188	CcSEcCtD
Lercanidipine—Rash—Valproic Acid—epilepsy syndrome	2.99e-05	0.000187	CcSEcCtD
Lercanidipine—Dermatitis—Valproic Acid—epilepsy syndrome	2.99e-05	0.000187	CcSEcCtD
Lercanidipine—Headache—Valproic Acid—epilepsy syndrome	2.97e-05	0.000186	CcSEcCtD
Lercanidipine—Paraesthesia—Topiramate—epilepsy syndrome	2.97e-05	0.000186	CcSEcCtD
Lercanidipine—Dyspnoea—Topiramate—epilepsy syndrome	2.95e-05	0.000185	CcSEcCtD
Lercanidipine—Somnolence—Topiramate—epilepsy syndrome	2.94e-05	0.000184	CcSEcCtD
Lercanidipine—Felodipine—ABCB1—epilepsy syndrome	2.94e-05	0.00622	CrCbGaD
Lercanidipine—Diarrhoea—Pregabalin—epilepsy syndrome	2.93e-05	0.000184	CcSEcCtD
Lercanidipine—Dyspepsia—Topiramate—epilepsy syndrome	2.91e-05	0.000183	CcSEcCtD
Lercanidipine—Hypersensitivity—Gabapentin—epilepsy syndrome	2.9e-05	0.000182	CcSEcCtD
Lercanidipine—Decreased appetite—Topiramate—epilepsy syndrome	2.88e-05	0.00018	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.86e-05	0.000179	CcSEcCtD
Lercanidipine—Fatigue—Topiramate—epilepsy syndrome	2.85e-05	0.000179	CcSEcCtD
Lercanidipine—Nifedipine—ABCB1—epilepsy syndrome	2.84e-05	0.00602	CrCbGaD
Lercanidipine—Dizziness—Pregabalin—epilepsy syndrome	2.84e-05	0.000178	CcSEcCtD
Lercanidipine—Constipation—Topiramate—epilepsy syndrome	2.83e-05	0.000177	CcSEcCtD
Lercanidipine—Asthenia—Gabapentin—epilepsy syndrome	2.82e-05	0.000177	CcSEcCtD
Lercanidipine—Nausea—Valproic Acid—epilepsy syndrome	2.82e-05	0.000177	CcSEcCtD
Lercanidipine—Nicardipine—ABCB1—epilepsy syndrome	2.8e-05	0.00592	CrCbGaD
Lercanidipine—Pruritus—Gabapentin—epilepsy syndrome	2.78e-05	0.000174	CcSEcCtD
Lercanidipine—Vomiting—Pregabalin—epilepsy syndrome	2.73e-05	0.000171	CcSEcCtD
Lercanidipine—Feeling abnormal—Topiramate—epilepsy syndrome	2.73e-05	0.000171	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.71e-05	0.00017	CcSEcCtD
Lercanidipine—Rash—Pregabalin—epilepsy syndrome	2.7e-05	0.000169	CcSEcCtD
Lercanidipine—Dermatitis—Pregabalin—epilepsy syndrome	2.7e-05	0.000169	CcSEcCtD
Lercanidipine—Diarrhoea—Gabapentin—epilepsy syndrome	2.69e-05	0.000169	CcSEcCtD
Lercanidipine—Headache—Pregabalin—epilepsy syndrome	2.69e-05	0.000168	CcSEcCtD
Lercanidipine—Urticaria—Topiramate—epilepsy syndrome	2.63e-05	0.000165	CcSEcCtD
Lercanidipine—Body temperature increased—Topiramate—epilepsy syndrome	2.62e-05	0.000164	CcSEcCtD
Lercanidipine—Abdominal pain—Topiramate—epilepsy syndrome	2.62e-05	0.000164	CcSEcCtD
Lercanidipine—Dizziness—Gabapentin—epilepsy syndrome	2.6e-05	0.000163	CcSEcCtD
Lercanidipine—Nausea—Pregabalin—epilepsy syndrome	2.55e-05	0.00016	CcSEcCtD
Lercanidipine—Vomiting—Gabapentin—epilepsy syndrome	2.5e-05	0.000157	CcSEcCtD
Lercanidipine—Rash—Gabapentin—epilepsy syndrome	2.48e-05	0.000155	CcSEcCtD
Lercanidipine—Dermatitis—Gabapentin—epilepsy syndrome	2.48e-05	0.000155	CcSEcCtD
Lercanidipine—Headache—Gabapentin—epilepsy syndrome	2.46e-05	0.000154	CcSEcCtD
Lercanidipine—Hypersensitivity—Topiramate—epilepsy syndrome	2.44e-05	0.000153	CcSEcCtD
Lercanidipine—Asthenia—Topiramate—epilepsy syndrome	2.37e-05	0.000149	CcSEcCtD
Lercanidipine—Pruritus—Topiramate—epilepsy syndrome	2.34e-05	0.000147	CcSEcCtD
Lercanidipine—Nausea—Gabapentin—epilepsy syndrome	2.34e-05	0.000146	CcSEcCtD
Lercanidipine—Diarrhoea—Topiramate—epilepsy syndrome	2.26e-05	0.000142	CcSEcCtD
Lercanidipine—Dizziness—Topiramate—epilepsy syndrome	2.19e-05	0.000137	CcSEcCtD
Lercanidipine—Vomiting—Topiramate—epilepsy syndrome	2.1e-05	0.000132	CcSEcCtD
Lercanidipine—Rash—Topiramate—epilepsy syndrome	2.09e-05	0.000131	CcSEcCtD
Lercanidipine—Dermatitis—Topiramate—epilepsy syndrome	2.08e-05	0.000131	CcSEcCtD
Lercanidipine—Headache—Topiramate—epilepsy syndrome	2.07e-05	0.00013	CcSEcCtD
Lercanidipine—Nausea—Topiramate—epilepsy syndrome	1.97e-05	0.000123	CcSEcCtD
Lercanidipine—CYP3A7—Metabolism—ASAH1—epilepsy syndrome	1.43e-05	0.000203	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—FGF2—epilepsy syndrome	1.41e-05	0.000201	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—VEGFA—epilepsy syndrome	1.4e-05	0.0002	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—STXBP1—epilepsy syndrome	1.39e-05	0.000198	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—MMP9—epilepsy syndrome	1.37e-05	0.000196	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.37e-05	0.000195	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—COX3—epilepsy syndrome	1.36e-05	0.000194	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NT5E—epilepsy syndrome	1.35e-05	0.000193	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ALAD—epilepsy syndrome	1.35e-05	0.000193	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.35e-05	0.000193	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—RELA—epilepsy syndrome	1.31e-05	0.000187	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ABCG2—epilepsy syndrome	1.3e-05	0.000186	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP2D6—epilepsy syndrome	1.29e-05	0.000185	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ALDH7A1—epilepsy syndrome	1.29e-05	0.000184	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CACNA1A—epilepsy syndrome	1.29e-05	0.000184	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CACNA2D2—epilepsy syndrome	1.29e-05	0.000184	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—KCNB1—epilepsy syndrome	1.29e-05	0.000184	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PFKL—epilepsy syndrome	1.29e-05	0.000184	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SLCO1A2—epilepsy syndrome	1.29e-05	0.000184	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SLC6A8—epilepsy syndrome	1.29e-05	0.000184	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP2C19—epilepsy syndrome	1.27e-05	0.000181	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—SRC—epilepsy syndrome	1.27e-05	0.000181	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.26e-05	0.00018	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ST3GAL3—epilepsy syndrome	1.26e-05	0.00018	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP11A1—epilepsy syndrome	1.26e-05	0.00018	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—FGF2—epilepsy syndrome	1.24e-05	0.000177	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ADSL—epilepsy syndrome	1.24e-05	0.000176	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—VEGFA—epilepsy syndrome	1.23e-05	0.000176	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ADRA2A—epilepsy syndrome	1.23e-05	0.000176	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—BCHE—epilepsy syndrome	1.23e-05	0.000175	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GLUL—epilepsy syndrome	1.21e-05	0.000173	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—FAR1—epilepsy syndrome	1.21e-05	0.000173	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CERS1—epilepsy syndrome	1.21e-05	0.000173	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ADK—epilepsy syndrome	1.21e-05	0.000173	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PDXK—epilepsy syndrome	1.21e-05	0.000173	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—L2HGDH—epilepsy syndrome	1.21e-05	0.000173	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GLUD1—epilepsy syndrome	1.21e-05	0.000173	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CACNA1D—epilepsy syndrome	1.19e-05	0.00017	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NEU1—epilepsy syndrome	1.18e-05	0.000168	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—UPB1—epilepsy syndrome	1.18e-05	0.000168	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ATIC—epilepsy syndrome	1.18e-05	0.000168	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—SLC2A1—epilepsy syndrome	1.17e-05	0.000167	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PLCB1—epilepsy syndrome	1.16e-05	0.000165	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—TH—epilepsy syndrome	1.15e-05	0.000165	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—RELA—epilepsy syndrome	1.15e-05	0.000164	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP2D6—epilepsy syndrome	1.14e-05	0.000162	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—HSD17B4—epilepsy syndrome	1.13e-05	0.000162	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—MMP9—epilepsy syndrome	1.11e-05	0.000159	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—TXNRD1—epilepsy syndrome	1.11e-05	0.000159	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PNPO—epilepsy syndrome	1.11e-05	0.000158	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NHLRC1—epilepsy syndrome	1.11e-05	0.000158	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GAMT—epilepsy syndrome	1.11e-05	0.000158	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—EPM2A—epilepsy syndrome	1.11e-05	0.000158	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PPP1R3C—epilepsy syndrome	1.1e-05	0.000156	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GBE1—epilepsy syndrome	1.1e-05	0.000156	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ADRA2A—epilepsy syndrome	1.08e-05	0.000154	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—AQP1—epilepsy syndrome	1.08e-05	0.000154	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—BCHE—epilepsy syndrome	1.08e-05	0.000154	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.04e-05	0.000149	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ASAH1—epilepsy syndrome	1.03e-05	0.000147	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—QDPR—epilepsy syndrome	1.03e-05	0.000147	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CA4—epilepsy syndrome	1.03e-05	0.000147	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—SLC2A1—epilepsy syndrome	1.03e-05	0.000147	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—SRC—epilepsy syndrome	1.03e-05	0.000147	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	1.02e-05	0.000146	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PLCB1—epilepsy syndrome	1.02e-05	0.000145	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—TH—epilepsy syndrome	1.01e-05	0.000145	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—STXBP1—epilepsy syndrome	1e-05	0.000143	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—VEGFA—epilepsy syndrome	1e-05	0.000143	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—MMP9—epilepsy syndrome	9.8e-06	0.00014	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CHRM3—epilepsy syndrome	9.77e-06	0.000139	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—KCNJ11—epilepsy syndrome	9.77e-06	0.000139	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NT5E—epilepsy syndrome	9.77e-06	0.000139	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ALAD—epilepsy syndrome	9.77e-06	0.000139	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—COX3—epilepsy syndrome	9.67e-06	0.000138	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—HMOX1—epilepsy syndrome	9.62e-06	0.000137	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CAT—epilepsy syndrome	9.49e-06	0.000136	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ALDH7A1—epilepsy syndrome	9.32e-06	0.000133	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CACNA1A—epilepsy syndrome	9.32e-06	0.000133	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ABCB1—epilepsy syndrome	9.24e-06	0.000132	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PFKL—epilepsy syndrome	9.16e-06	0.000131	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	9.16e-06	0.000131	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	9.16e-06	0.000131	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	9.16e-06	0.000131	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	9.16e-06	0.000131	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ST3GAL3—epilepsy syndrome	9.12e-06	0.00013	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—SRC—epilepsy syndrome	9.03e-06	0.000129	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ADSL—epilepsy syndrome	8.93e-06	0.000128	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—VEGFA—epilepsy syndrome	8.8e-06	0.000126	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GLUL—epilepsy syndrome	8.76e-06	0.000125	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CACNA1D—epilepsy syndrome	8.6e-06	0.000123	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GPX1—epilepsy syndrome	8.59e-06	0.000123	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—TNF—epilepsy syndrome	8.58e-06	0.000122	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—HMOX1—epilepsy syndrome	8.45e-06	0.000121	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NEU1—epilepsy syndrome	8.38e-06	0.00012	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—UPB1—epilepsy syndrome	8.38e-06	0.00012	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ATIC—epilepsy syndrome	8.38e-06	0.00012	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CAT—epilepsy syndrome	8.34e-06	0.000119	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ABCB1—epilepsy syndrome	8.11e-06	0.000116	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	8.07e-06	0.000115	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—TXNRD1—epilepsy syndrome	8.04e-06	0.000115	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ABCG2—epilepsy syndrome	7.96e-06	0.000114	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—FAR1—epilepsy syndrome	7.9e-06	0.000113	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	7.9e-06	0.000113	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PDXK—epilepsy syndrome	7.9e-06	0.000113	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CERS1—epilepsy syndrome	7.9e-06	0.000113	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	7.9e-06	0.000113	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ADK—epilepsy syndrome	7.9e-06	0.000113	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—AQP1—epilepsy syndrome	7.81e-06	0.000111	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	7.79e-06	0.000111	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GBE1—epilepsy syndrome	7.79e-06	0.000111	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP2C19—epilepsy syndrome	7.76e-06	0.000111	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP11A1—epilepsy syndrome	7.71e-06	0.00011	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GPX1—epilepsy syndrome	7.54e-06	0.000108	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—TNF—epilepsy syndrome	7.54e-06	0.000108	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—AGT—epilepsy syndrome	7.53e-06	0.000107	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—APOE—epilepsy syndrome	7.38e-06	0.000105	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	7.33e-06	0.000105	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.23e-06	0.000103	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.23e-06	0.000103	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.23e-06	0.000103	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.23e-06	0.000103	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	7.13e-06	0.000102	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	7.06e-06	0.000101	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	7.06e-06	0.000101	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	6.96e-06	9.94e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NT5E—epilepsy syndrome	6.94e-06	9.91e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ALAD—epilepsy syndrome	6.94e-06	9.91e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CA4—epilepsy syndrome	6.72e-06	9.6e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	6.72e-06	9.6e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	6.7e-06	9.57e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	6.63e-06	9.46e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	6.62e-06	9.46e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	6.62e-06	9.46e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—AGT—epilepsy syndrome	6.62e-06	9.44e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—BCHE—epilepsy syndrome	6.6e-06	9.42e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	6.48e-06	9.25e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—APOE—epilepsy syndrome	6.48e-06	9.25e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—AKT1—epilepsy syndrome	6.39e-06	9.12e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ADSL—epilepsy syndrome	6.35e-06	9.07e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—POMC—epilepsy syndrome	6.34e-06	9.05e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.32e-06	9.02e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	6.29e-06	8.99e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GLUL—epilepsy syndrome	6.23e-06	8.89e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	6.23e-06	8.89e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—TH—epilepsy syndrome	6.2e-06	8.86e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	6.11e-06	8.73e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.99e-06	8.55e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.99e-06	8.55e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.99e-06	8.55e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.99e-06	8.55e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.99e-06	8.55e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ALB—epilepsy syndrome	5.78e-06	8.25e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	5.76e-06	8.22e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	5.72e-06	8.16e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—AKT1—epilepsy syndrome	5.61e-06	8.01e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	5.61e-06	8.01e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	5.57e-06	7.96e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—POMC—epilepsy syndrome	5.57e-06	7.95e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	5.55e-06	7.93e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.48e-06	7.82e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.48e-06	7.82e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.48e-06	7.82e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.27e-06	7.53e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	5.18e-06	7.39e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CAT—epilepsy syndrome	5.11e-06	7.29e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.09e-06	7.27e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.09e-06	7.27e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ALB—epilepsy syndrome	5.08e-06	7.25e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PTGS2—epilepsy syndrome	5.05e-06	7.22e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	5.03e-06	7.18e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.02e-06	7.17e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.02e-06	7.17e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	4.97e-06	7.09e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.79e-06	6.84e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	4.79e-06	6.84e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—BCHE—epilepsy syndrome	4.77e-06	6.81e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.66e-06	6.65e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GPX1—epilepsy syndrome	4.62e-06	6.6e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	4.55e-06	6.5e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.54e-06	6.48e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.54e-06	6.48e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	4.5e-06	6.42e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—TH—epilepsy syndrome	4.48e-06	6.4e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PTGS2—epilepsy syndrome	4.44e-06	6.34e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.33e-06	6.18e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.33e-06	6.18e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.24e-06	6.05e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.15e-06	5.93e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.09e-06	5.84e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.07e-06	5.81e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—AGT—epilepsy syndrome	4.05e-06	5.78e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4e-06	5.71e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.99e-06	5.69e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—APOE—epilepsy syndrome	3.97e-06	5.67e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.96e-06	5.66e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	3.74e-06	5.34e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.74e-06	5.34e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CAT—epilepsy syndrome	3.69e-06	5.27e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.63e-06	5.18e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	3.59e-06	5.13e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—POMC—epilepsy syndrome	3.41e-06	4.87e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.41e-06	4.86e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.39e-06	4.84e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GPX1—epilepsy syndrome	3.34e-06	4.77e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.28e-06	4.69e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.28e-06	4.69e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.24e-06	4.62e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.2e-06	4.57e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—TH—epilepsy syndrome	3.19e-06	4.55e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ALB—epilepsy syndrome	3.11e-06	4.44e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—AGT—epilepsy syndrome	2.93e-06	4.18e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—APOE—epilepsy syndrome	2.87e-06	4.1e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	2.72e-06	3.88e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.68e-06	3.82e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.66e-06	3.8e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.63e-06	3.75e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.61e-06	3.72e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.59e-06	3.7e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.55e-06	3.65e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—AKT1—epilepsy syndrome	2.54e-06	3.63e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—POMC—epilepsy syndrome	2.46e-06	3.52e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.37e-06	3.39e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.34e-06	3.34e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ALB—epilepsy syndrome	2.25e-06	3.21e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—AKT1—epilepsy syndrome	2.23e-06	3.19e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.23e-06	3.18e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.22e-06	3.17e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.12e-06	3.02e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.09e-06	2.99e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TH—epilepsy syndrome	2.08e-06	2.98e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.08e-06	2.97e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.04e-06	2.91e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.97e-06	2.81e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.75e-06	2.5e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.74e-06	2.48e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.72e-06	2.45e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.67e-06	2.38e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.6e-06	2.28e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.55e-06	2.22e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.4e-06	2e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—AKT1—epilepsy syndrome	1.37e-06	1.95e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.36e-06	1.94e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.33e-06	1.9e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.15e-06	1.64e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.04e-06	1.49e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—AKT1—epilepsy syndrome	9.88e-07	1.41e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.14e-07	1.3e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	7.03e-07	1e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.59e-07	6.56e-06	CbGpPWpGaD
